4.7 Letter

mcr-1 and blaKPC-3 in Escherichia coli Sequence Type 744 after Meropenem and Colistin Therapy, Portugal

期刊

EMERGING INFECTIOUS DISEASES
卷 23, 期 8, 页码 1419-1421

出版社

CENTERS DISEASE CONTROL
DOI: 10.3201/eid2308.170162

关键词

-

资金

  1. Fundacao para a Ciencia e a Tecnologia (FCT) through CESAM [UID/AMB/50017/2013]
  2. ESF (EU)
  3. POPH funds (Programa Investigador FCT) [IF/00492/2013]
  4. FCT [SFRH/BPD/81509/2011, SFRH/BPD/114855/2016]
  5. Fundação para a Ciência e a Tecnologia [SFRH/BPD/114855/2016, SFRH/BPD/81509/2011] Funding Source: FCT

向作者/读者索取更多资源

Escherichia coli Ec36 was recovered from a patient in Portugal after treatment with meropenem and colistin. Besides an IncF plasmid with Tn1441d-blaKPC-3, already reported in clinical strains in this country, E. coli Ec36 co-harbored an IncX4:: mcr-1 gene. Results highlight emerging co-resistance to carbapenems and polymyxins after therapy with drugs from both classes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据